It’s generally known that Alzheimer’s disease is a neurological condition that primarily targets the brain. However, new information suggests that it actually starts somewhere else in the body. As such, scientists are suggesting to take even better care of one’s physical and mental health to reduce the chances of developing the degenerative condition.
The new data was presented by a joint effort of Canadian and Chinese researchers who posted their findings on the Molecular Psychiatry journal. According to their study, Alzheimer’s might actually start somewhere other than the brain. This is due to how the condition is caused by the build-up of beta-amyloid proteins and tau proteins.
“In this study, using a model of parabiosis between APPswe/PS1dE9 transgenic AD mice and their wild-type littermates, we observed that the human Aβ originated from transgenic AD model mice entered the circulation and accumulated in the brains of wild-type mice, and formed cerebral amyloid angiopathy and Aβ plaques after a 12-month period of parabiosis,” the paper reads.
The key takeaway here is the beta-amyloid build-up because this protein is actually produced by other parts of the body. At any given moment, the human body produces the protein, which then crosses the blood-brain barrier. As a result, the protein gets stuck in the brain, which results in Alzheimer’s.
These findings could result in a huge shift in how the degenerative disease might be approached in the future. Right now, Alzheimer’s treatments largely focus on the brain, Futurism reports. As this study suggests, however, scientists might want to look into other parts of the body. More specifically, perhaps more focus should be given to the build-up of beta-amyloid.
Doing so could finally alleviate the burden that the care of patients with Alzheimer’s or dementia is causing. In 2016 alone, the U.S. has spent $236 billion in caring for such patients.


Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity
Trump Says Anthropic No Longer Seen as National Security Threat
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation
SK Hynix Overtakes Samsung as South Korea’s Most Valuable Company
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow
Trump’s Quantum Push Lifts IBM Stock as CEO Arvind Krishna Receives White House Praise
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White
How AI prompting turned writerly description into an everyday skill
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 



